VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Ropivacaine and Dexmedetomidine
Phase 1
Small molecule
Q
Qianfoshan Hospital
1
Indications
3
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Erector Spinae Block
1 trial
Erector Spinae Block With Ropivacaine and Dexmedetomidine on Opioid Consumption After Lumar Spine Surgeries
Unknown status
·
S
Security Forces Hospital
·
Phase 4
·
NCT05664542
·
42 enrolled
Agitation
1 trial
Effect of Different Administration Routes of Dexmedetomidine Combined with Ultrasound-Guided Fascia Iliaca Block on Emergence Agitation After Hip Replacement Surgery
Recruiting
·
Q
Qianfoshan Hospital
·
Phase 1
·
NCT06614010
·
207 enrolled
Supraclavicular Brachial Plexus Block
1 trial
Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block
Completed
·
—
·
Phase 3
·
NCT02787018
·
120 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
3 trial records for Ropivacaine and Dexmedetomidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Ropivacaine and Dexmedetomidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Ropivacaine and Dexmedetomidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Qianfoshan Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 1
[1]
Company
Q
Qianfoshan Hospital
Related News